Dr. Pooja Motwani, MD

Dr. Motwani practices at Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian.

Dr. Motwani's NPI, 1134315880, was assigned on September 17, 2007. Dr. Motwani holds Arkansas license E-5406.

Dr. Motwani's primary practice is Hoag Hospital Newport Beach, at One Hoag Drive, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 764-4624. Dr. Motwani also practices at Hoag Hospital Newport Beach, 1 Hoag Dr, Newport Beach, CA 92663.

Dr. Motwani's primary practice is Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian. Dr. Motwani is also affiliated with UCI Health - Orange. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Motwani to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Motwani practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Motwani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Motwani is licensed in Arkansas.

CMS data shows 718 Medicare services from Dr. Motwani across 6 procedure codes in 2024, for 246 Medicare patients. Medicare paid $64,159 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 246 Medicare patients who saw Dr. Motwani in 2024. The largest group is 75 to 84, with 114 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Motwani's median patient age at 72, with 61% women.

In 2024, Dr. Motwani wrote 1,157 Medicare Part D claims for 140 patients. 73% of them were for generic drugs. CMS names the drug for 905 of them, across 30 drugs with 11 or more claims each, at $3,489,053 in total drug cost. In 2023, CMS named 685 claims across 26 drugs.

Dr. Motwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Motwani as offering telehealth.

CMS Open Payments shows 60 general payments to Dr. Motwani from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. AstraZeneca Pharmaceuticals LP paid the most, $11,055.